ARHGAP5 and breast cancer: Our results indicate that ARHGAP5, a prognosis indicator of BC, serves as miR-516b-5p’s target, and may act as the effector protein of circUBE2K through a circUBE2K-miR-516-5p-ARHGAP5 regulation mechanism.